TNF-alpha inhibitors for ankylosing spondylitis.

Maxwell, Lara J; Zochling, Jane; Boonen, Annelies; Singh, Jasvinder A; Veras, Mirella M S; Tanjong Ghogomu, Elizabeth; Benkhalti Jandu, Maria; Tugwell, Peter; Wells, George A

Maxwell, Lara J; Zochling, Jane; Boonen, Annelies; Singh, Jasvinder A; Veras, Mirella M S; Tanjong Ghogomu, Elizabeth; Benkhalti Jandu, Maria; Tugwell, Peter; Wells, George A.

Affiliation

Maxwell LJ; Centre for Practice-Changing Research (CPCR), Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital - General Campus, 501 Smyth Road, Box 711, Ottawa, ON, Canada, K1H 8L6.

Cochrane Database Syst Rev ; (4): CD005468, 2015 Apr 18.

Article in En | MEDLINE | ID: mdl-25887212

Subject(s)

Spondylitis, Ankylosing/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Etanercept; Humans; Immunoglobulin G/therapeutic use; Infliximab; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spondylitis, Ankylosing / Tumor Necrosis Factor-alpha Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2015 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google